Treatment of tissue extravasation by antitumor agents
Open Access
- 1 May 1982
- Vol. 49 (9) , 1796-1799
- https://doi.org/10.1002/1097-0142(19820501)49:9<1796::aid-cncr2820490911>3.0.co;2-m
Abstract
Infiltration of antitumor agents into subcutaneous tissues may either result in a local area of self‐resolving inflammation, or progress to full‐thickness loss of skin and underlying vital structures. The immediate treatment of 50 extravasations occurring over a 20‐month period resulted in our developing a protocol of appropriate care. Once extravasation is suspected, the intravenous line is removed, ice is applied intermittently for three days, and the wound is observed closely. No drugs are ever given locally. If local pain persists or skin changes progress, the area of involvement is debrided and, a skin graft is applied two to three days later. As a result of this conservative approach, only 12 of 50 patients have required surgery. This method of treatment has minimized patient morbidity, hospitalizations, and loss of synchronization of chemotherapy.This publication has 16 references indexed in Scilit:
- Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugsCancer Treatment Reviews, 1980
- Histopathogenesis of Skin and Subcutaneous Injury Induced by AdriamycinPlastic and Reconstructive Surgery, 1979
- The management of inadvertent subcutaneous adriamycin infiltrationThe American Journal of Surgery, 1979
- The quantitative and qualitative impairment of wound healing by adriamycinCancer, 1979
- ADRIAMYCIN EXTRAVASATIONPlastic and Reconstructive Surgery, 1978
- Clinical course and management of accidental adriamycin extravasationCancer, 1977
- Skin ulcers due to adriamycinCancer, 1976
- Recall Injury from AdriamycinAnnals of Internal Medicine, 1975
- Adriamycin Activating a Recall Phenomenon After Radiation TherapyAnnals of Internal Medicine, 1974
- Therapeutic effect and toxicity of adriamycin in patients with neoplastic diseaseCancer, 1971